Signify Health, Inc. 4 SEC Filings

Filed On	Filing
29 Mar 2023	Form 4: Builder Josh, Chief Technology Officer Received 145,011 shares by conversion · Returned 271,455 shares to the issuer · Returned 145,011 shares to the issuer · 1 more
29 Mar 2023	Form 4: Armbrester Bradford Kyle, Director Received 5,991,078 shares by conversion · Returned 6,372,644 shares to the issuer · Returned 5,991,078 shares to the issuer · 1 more
29 Mar 2023	Form 4: Rothman Marc D, Chief Medical Officer Received 120,837 shares by conversion · Returned 189,073 shares to the issuer · Returned 120,837 shares to the issuer · 1 more
29 Mar 2023	Form 4: Dixon Heather Brianne, Director Returned 29,674 shares to the issuer
29 Mar 2023	Form 4: Notini Albert A, Director Returned 14,672 shares to the issuer
29 Mar 2023	Form 4: Senneff Steve, Pres. Chief Fin. & Admin. Off. Received 506,975 shares by conversion · Returned 809,307 shares to the issuer · Returned 506,975 shares to the issuer · 1 more
29 Mar 2023	Form 4: McAnaney Adam, General Counsel and Secretary Received 24,173 shares by conversion · Returned 154,199 shares to the issuer · Returned 24,173 shares to the issuer · 1 more
29 Mar 2023	Form 4: Pierre David, Chief Operating Officer Received 772,875 shares by conversion · Returned 972,056 shares to the issuer · Returned 772,875 shares to the issuer · 1 more
29 Mar 2023	Form 4: Riefberg Vivian E., Director Received 24,173 shares by conversion · Returned 60,661 shares to the issuer · Returned 24,173 shares to the issuer
29 Mar 2023	Form 4: Orton Laurence Michael, Chief Operating Officer Returned 32,734 shares to the issuer · Disposed of 186,770 Employee Stock Options (Right to Buy) (Disposition to Issuer)
29 Mar 2023	Form 4: Gronniger Tim, Ch. Value-Based Sols. Off Returned 323,584 shares to the issuer · Disposed of 132,138 Employee Stock Options (Right to Buy) (Disposition to Issuer)
29 Mar 2023	Form 4: Peterson Kyle B., Director Returned 14,672 shares to the issuer
29 Mar 2023	Form 4: Goldberg Arnold, Director Returned 32,744 shares to the issuer
29 Mar 2023	Form 4: Farazi Paymon, Chief Product Officer Returned 237,269 shares to the issuer · Disposed of 142,125 Employee Stock Options (Right to Buy) (Disposition to Issuer)
29 Mar 2023	Form 4: Mcnamara Kevin M, Director Received 1,260,850 shares by conversion · Returned 1,283,438 shares to the issuer · Returned 1,260,850 shares to the issuer
29 Mar 2023	Form 4: Holt Matthew S., Director Returned 14,672 shares to the issuer
29 Mar 2023	Form 4: Hull Brandon H, Director Received 1,030,500 shares by conversion · Returned 1,066,988 shares to the issuer · Returned 1,030,500 shares to the issuer
29 Mar 2023	Form 4: Clayton Taj J., Director Received 24,173 shares by conversion · Returned 50,329 shares to the issuer · Returned 24,173 shares to the issuer
09 Mar 2023	Form 4: Armbrester Bradford Kyle, Director Gave up 6,369 shares to cover exercise price or tax ($181K)
09 Mar 2023	Form 4: Rothman Marc D, Chief Medical Officer Gave up 2,736 shares to cover exercise price or tax ($77.6K)

Comments